Bausch & Lomb (BLCO) Gross Margin (2021 - 2026)

Bausch & Lomb (BLCO) reported Gross Margin of 78.22% for Q1 2026, down 974.0% on a YoY basis from 8.95% in Q1 2025, and down 21.51% quarter-over-quarter from 99.64% in Q4 2025.

Bausch & Lomb (BLCO) Gross Margin (2021 - 2026) Analysis & Trends

Bausch & Lomb has reported Gross Margin for 6 years, with the latest figure at 78.22% in Q1 2026.

  • For the quarter ending Q1 2026, Gross Margin fell 974.0% year-over-year to 78.22%; the trailing twelve-month figure through Mar 2026 stood at 82.28% (down 3924.0% YoY), and the FY2025 full-year result was 99.9%, down 1.0% from the prior year.
  • Gross Margin for Q1 2026 stood at 78.22%, down from 99.64% in the prior quarter.
  • The five-year high for Gross Margin was 206.64% in Q4 2024, with the low at 39.64% in Q4 2023.
  • Historically, Gross Margin has averaged 86.81% across 5 years, with a median of 87.95% in 2025.
  • Annual changes were most pronounced in 2023 — Gross Margin tumbled 22759 bps — and 2024, when it soared 24628 bps.
  • Bausch & Lomb's Gross Margin stood at 187.95% in 2022, then slumped by 121 bps to 39.64% in 2023, then soared by 621 bps to 206.64% in 2024, then tumbled by 52 bps to 99.64% in 2025, then fell by 22 bps to 78.22% in 2026.
  • The last three Gross Margin figures came in at 78.22% (Q1 2026), 99.64% (Q4 2025), and 90.32% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn 66.06%
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn 45.69%
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn 25.04%
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 62.25%
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 35.08%
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn 54.66%
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn 68.00%
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn 70.82%
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn 32.99%
10 Bausch & Lomb 5.32 Bn 5.12 Bn 973.00 Mn 78.22%

Historic Data

Download Data
DateValue
Mar 31, 2026 78.22%
Dec 31, 2025 99.64%
Sep 30, 2025 90.32%
Jun 30, 2025 59.08%
Mar 31, 2025 87.95%
Dec 31, 2024 206.64%
Sep 30, 2024 92.22%
Jun 30, 2024 92.11%
Mar 31, 2024 79.53%
Dec 31, 2023 -39.64%
Sep 30, 2023 61.17%
Jun 30, 2023 100.00%
Mar 31, 2023 60.15%
Dec 31, 2022 187.95%
Sep 30, 2022 60.72%
Jun 30, 2022 59.94%
Mar 31, 2022 99.78%
Dec 31, 2021 99.90%
Sep 30, 2021 99.68%
Jun 30, 2021 61.03%